Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00731939
Other study ID # DK057CC
Secondary ID
Status Completed
Phase N/A
First received August 7, 2008
Last updated March 7, 2014
Start date November 2007
Est. completion date April 2010

Study information

Verified date March 2014
Source Coloplast A/S
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardCanada: Health CanadaUnited Kingdom: Medicines and Healthcare Products Regulatory AgencyFrance: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the ease of deflation of the Titan® OTR pump.


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date April 2010
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Participant has an estimated life expectancy of more than 5 years

- Participant has been diagnosed with erectile dysfunction (impotence)

- participant is willing to have the Titan OTR IPP implanted

- Participant is able and willing to complete all follow-up visits and procedures indicated in the protocol

Exclusion Criteria:

- Participant is unable or unwilling to sign the Informed Consent Form and /or comply with all follow-up requirements according to the study protocol

- Participant had a previous penile prosthesis or prior penile enlargement surgeries

- Participant has a compromised immune system, such as systemic lupus erythematosus, discoid lupus, or scleroderma

- Participant has had a myocardial infarction or coronary artery stent placement within 2 months prior to treatment

- Participant currently has uncontrolled or severe diabetes or other disease significantly reducing wound healing ability

- Participant does not have the manual dexterity or mental ability to operate the pump

- Participant has chordee or priapism

- Participant has penile sensory neuropathy

- Participant has serious bleeding disorder

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Inflatable Penile Prosthesis
Hydraulic system designed to be surgically implanted into the penis for the management of erectile dysfunction.

Locations

Country Name City State
Canada St Joseph's Hospital London Ontario
United Kingdom University College London Hospital London UK
United States Emory Healthcare Altanta Georgia
United States Michigan Urology Center Ann Arbor Michigan
United States Boston Medical Center Boston Massachusetts
United States Rush Presbyterian Chicago Illinois
United States Carolina Urologic Research Center Myrtle Beach South Carolina
United States Urology San Antonio San Antonio Texas

Sponsors (1)

Lead Sponsor Collaborator
Coloplast A/S

Countries where clinical trial is conducted

United States,  Canada,  United Kingdom, 

References & Publications (1)

Ohl DA, Brock G, Ralph D, Bogache W, Jones L, Munarriz R, Levine L, Ritenour C. Prospective evaluation of patient satisfaction, and surgeon and patient trainer assessment of the Coloplast titan one touch release three-piece inflatable penile prosthesis. J — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Assess the Ease of Deflation of the Titan® OTR Pump The study's primary endpoint was to demonstrate that at least 64% of subjects were mostly or completely satisfied with the ability to deflate the device at the 6-month follow-up. The study's primary objective was to assess the ease of deflation of the Titan® OTR pump via subject questionnaire at 6-month follow-up. Subjects were asked via questionnaire how satisfied they were with ease of deflation of their implant. Success criteria was a response of "satisfactory" or "somewhat satisfactory". Other possible responses were "neither satisfactory nor unsatisfactory", "somewhat unsatisfactory", and "very unsatisfactory". 6 months No
Secondary Evaluate User Acceptance of Titan® OTR - Question 1 Subject Satisfaction - overall function 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 1 Subject Satisfaction - overall function 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 1 Subject Satisfaction - overall function 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 2 Subject Satisfaction - soft enough to conceal when deflated 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 2 Subject Satisfaction - soft enough to conceal when deflated 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 2 Subject Satisfaction - soft enough to conceal when deflated 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 3 Subject Satisfaction - ease of locating the deflation touch pads 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 3 Subject Satisfaction - ease of locating the deflation touch pads 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 3 Subject Satisfaction - ease of locating the deflation touch pads 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 4 Subject Satisfaction - ease of inflation 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 4 Subject Satisfaction - ease of inflation 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 4 Subject Satisfaction - ease of inflation 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 5 Subject Satisfaction - ease of deflation 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 5 Subject Satisfaction - ease of deflation 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 5 Subject Satisfaction - ease of deflation 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 6 Subject Satisfaction - hardness of erection when inflated 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 6 Subject Satisfaction - hardness of erection when inflated 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 6 Subject Satisfaction - hardness of erection when inflated 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 7 Subject Satisfaction - width when inflated 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 7 Subject Satisfaction - width when inflated 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 7 Subject Satisfaction - width when inflated 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 8 Subject Satisfaction - length when inflated 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 8 Subject Satisfaction - length when inflated 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 8 Subject Satisfaction - length when inflated 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 9 Subject Satisfaction - would you recommend this penile implant device to men with the same erectile difficulty that you had? 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 9 Subject Satisfaction - would you recommend this penile implant device to men with the same erectile difficulty that you had? 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 9 Subject Satisfaction - would you recommend this penile implant device to men with the same erectile difficulty that you had? 12 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 10 Subject Satisfaction - if you had the decision to make again, would you undergo this penile implant procedure again? 3 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 10 Subject Satisfaction - if you had the decision to make again, would you undergo this penile implant procedure again? 6 months post-surgery No
Secondary Evaluate User Acceptance of Titan® OTR - Question 10 Subject Satisfaction - if you had the decision to make again, would you undergo this penile implant procedure again? 12 months post-surgery No
Secondary Assess the Ease of Implant of the Titan® OTR Question 1 Titan OTR pre-implant product preparation was straightforward/simple? At implant No
Secondary Assess the Ease of Implant of the Titan® OTR - Question 2 Titan OTR pre-implant product preparation was easier than your usual pump of choice? At implant No
Secondary Assess the Ease of Implant of the Titan® OTR - Question 3 The subject was easily able to accommodate the OTR pump? At implant No
Secondary Assess the Ease of Training for Titan® OTR - Question 1 It was easy for the subject to find the inflation bulb? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 2 It was easy for the subject to find the deflation touch pads? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 3 It was easy for the subject to inflate the device? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 4 It was easy for the subject to compress the deflation touch pads? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 5 Subject training with OTR pump was easier than with previous pump? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 6 The OTR pump was easy to use at 1st cycling? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 7 The subject likes the OTR pump? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 8 How easy was it for the subject to learn? 6 weeks No
Secondary Assess the Ease of Training for Titan® OTR - Question 9 How likely the subject will need continued training or retraining? 6 weeks No
Secondary Assess Partner Satisfaction (Where Applicable) The Partner Treatment Satisfaction Scale (TSS) was used. The TSS provides scores ranging from 0 to 100 in 5 domains of Ease of erection, Erectile function, Pleasure from sexual activity, Satisfaction with orgasm and Confidence to complete sexual activity with higher scores indicative of worse symptoms. Available data is summarized for each domain at each visit along with change from baseline. Baseline No
Secondary Assess Partner Satisfaction (Where Applicable) The Partner Treatment Satisfaction Scale (TSS) was used. The TSS provides scores ranging from 0 to 100 in 5 domains of Ease of erection, Erectile function, Pleasure from sexual activity, Satisfaction with orgasm and Confidence to complete sexual activity with higher scores indicative of worse symptoms. Available data is summarized for each domain at each visit along with change from baseline. 6 months No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05366504 - LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment Phase 2/Phase 3
Recruiting NCT02573805 - the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males N/A
Recruiting NCT02745808 - Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes Phase 1
Withdrawn NCT02579148 - Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes Phase 1
Withdrawn NCT01967251 - Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction Phase 2
Recruiting NCT02225548 - Sagene 2014 - Parkinson's Disease and Erectile Dysfunction Phase 4
Completed NCT02587988 - Trial to Evaluate the Efficacy and Safety of HCP1302 Phase 3
Completed NCT01937871 - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) Phase 3
Completed NCT02945462 - Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED) Phase 1
Completed NCT01698684 - Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction Phase 4
Not yet recruiting NCT01321489 - A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies Phase 3
Completed NCT02226237 - Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy N/A
Terminated NCT01262833 - Pudendal Assessment in Erectile Dysfunction N/A
Completed NCT01230541 - Effect of Udenafil on Spermatogenesis Phase 1
Completed NCT01037244 - Treatment of Erectile Dysfunction I Phase 3
Completed NCT01037218 - Treatment of Erectile Dysfunction II Phase 3
Recruiting NCT00313898 - Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males Phase 4
Completed NCT00421083 - Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury Phase 3
Completed NCT00663728 - Assessment of Duration of Erection With Vardenafil 10 mg Phase 4
Completed NCT00667979 - Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse Phase 4